量化多巴胺激动剂抗帕金森药物副作用的耐受性:最好最坏的缩放调查
Kristin Richards1, Anton L V Avanceña1,2, Michael Johnsrud1
1TxCORE and Health Outcomes Division, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA.
Patient preference and adherence
|March 3, 2026
概括
患有帕金森病 (PwP) 的人发现嗜睡,幻觉和强迫行为是多巴胺激动剂 (DA) 最不能忍受的副作用. 耐受性显著影响治疗决策,强调了PwP与医疗保健提供者之间需要进行公开讨论的必要性.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 患者报告的结果
背景情况:
- 多巴胺激动剂 (DA) 对于治疗帕金森病 (PD) 至关重要.
- 了解患者对DA副作用的耐受性对于治疗坚持至关重要.
- 以前的研究还没有完全阐明哪些特定的副作用是帕金森病 (PwP) 患者最多和最不耐受的.
研究的目的:
- 对于患有帕金森病 (PwP) 的人来说,确定多巴胺激动剂 (DA) 药物的最多和最不耐受的副作用.
- 调查副作用耐受性如何影响普华永道关于启动和继续DA治疗的决定.
主要方法:
- 对102名PwP和护理合作伙伴的代理人进行了在线调查.
- 最好的最坏的缩放 (BWS) 用于评估患者对10个已识别的DA副作用的耐受性.
- 进行描述性和统计分析来解释数据.
主要成果:
- 突然/压倒性的嗜睡,幻觉和强迫行为被确定为最不耐受的副作用.
- 据报道,头,头痛和恶心是最可容忍的副作用.
- 较不耐受的副作用与开始或继续DA治疗的意愿降低有关.
结论:
- 患者对副作用的耐受性显著影响帕金森病的治疗开始和继续.
- 医疗保健提供者应在治疗前和治疗期间主动与PwP讨论DA副作用的情况.
- 关于副作用的公开沟通可以提高治疗坚持和改善普华永道的健康结果.
相关概念视频
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Agonism and Antagonism: Quantification
1.4K
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.4K
Drug Dosing: Geriatric Patients
395
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
Drug Toxicity: Dose-Dependent Reactions
229
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
229
Dose Response Curve: Conventional Versus Nonmonotonic
371
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response...
371
Drug Therapy
449
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
449


